Infectious Disease and HIV Specialty Practice Group

Welcome and thank you for your interest in the AANP Infectious Disease and HIV Community. I am honored to serve as one of the group's co-chairs. As a certified Adult-Gerontology Primary Care Nurse Practitioner, I have been working in the field of HIV since 1997. I have served as the national President for the Association of Nurses in AIDS Care (ANAC) and am the Co-medical Director for the American Academy of HIV Medicine's HIV Age initiative. In addition to my clinical practice in New York, I am a professor at Rutgers University in New Jersey. My areas of interest include HIV and aging, PrEP, HIV and hepatitis co-infection, STIs and other emerging diseases. I look forward to dialoguing, supporting, advocating and learning from all members of this specialty group.

Dr. Jason Farley is an Endowed Professor of Nursing Innovation and Leadership at The Johns Hopkins University School of Nursing where he also founded and directs the Center for Infectious Disease and Nursing Innovation (CIDNI.org). As an infectious disease nurse epidemiologist and an ID adult nurse practitioner in the Division of Infectious Diseases at The Johns Hopkins School of Medicine, his 19 years of clinical practice in the John Bartlett ID Specialty Practice spans HIV prevention, treatment and associated co-infections. His program of ID research seeks to optimize a patient’s diagnostic experience, navigation and linkage to care, and their retention in ID care. He designs multi-component interventions to build an equitable care experience tailored to the patient’s individual needs. He is the principal investigator on a cluster-randomized trial [R01AI104488] designed to tailor nurse case management for persons with drug-resistant Tuberculosis and HIV co-infection in South Africa and a co-investigator on an adaptive, SMART trial [R01 NR016650], which involves an adaptive randomized evaluation of nurse-led HIV treatment and retention interventions for female sex workers living with HIV, also in South Africa. His team recently launched a randomized controlled trial to improve treatment adherence and retention in care for patients with TB and HIV co-infection using a combined community health worker armed with digital adherence technology to escalate adherence support in real-time. In an ongoing interventional cohort in Baltimore City, Maryland, his community health worker model offers an ‘unapologetically enabling’ approach to achieve equitable access, retention and engagement for patients struggling with viral suppression. His team recently pivoted their expertise in diagnosis and linkage to care for patients with SARS-CoV-2, receiving a CFAR supplement to conduct a comparative effectiveness trial of COVID-19 testing modalities. He is presently the lead for the Johns Hopkins Coronavirus Prevention Network (CoVPN) studies. He is a clinical core co-director of the Johns Hopkins Center for AIDS Research and a development core co-director in the TB Research Advancement Center.